2025 Speakers
Nikhil Mutyal
Head of Search &
Evaluation, Respiratory
& Immunology
AstraZeneca
Nick Veomett
Vice President, Corporate Development
Artiva Biotherapeutics
Shanshan Xu
Chief Executive Officer
Bambusa Therapeutics
Zaneta Odrowaz
Chief Business Officer
Attovia Therapeutics
Daniel Passeri
President & Chief
Executive Officer
Cue Biopharma
Hussein Al-Mossawi
Vice President,
Immunology Research
Immunocore
Gregory Frost
Chief Executive Officer
Exuma Bio
Avirup Bose
Vice President, Corporate Development
InduPro
Jonathan Zombeck
Director, Business
Development
Visterra
Nicola La Monica
Senior Director, Strategic Search & Evaluation
Johnson & Johnson
Dan Maziasz
Chief Business Officer
Kyverna Therapeutics
Vikas Goyal
Partner, Growth & Investments
Longwood Funds
Carolyn Tyler
Senior Director
McQuade Center for Strategic Research & Development
Otsuka
Javad Rasouli
Associate Director,
Business Development
Otsuka
Carter King
Executive Vice President, Business
Development
Protagonist Therapeutics
Stuart Chaffee
Chief Executive Officer
QuantX Biosciences
Saifur Rahman
Director, Search & Evaluation,
Immunology Sanofi
Partnering
Sanofi
Neil Abdollahian
Chief Business Officer
Santa Ana Bio
Paras Doshi
Director, Business Development
Seismic Therapeutic
Tayo Sanders
Chief Business Officer
Singular Immune
Shinichiro Fuse
Partner & Managing
Director
TPG
Thrilled to join peers at the Autoimmunity Summit - while we've seen remarkable progress in the field, there's still such a long road ahead for patients. "I'm eager to learn from everyone's journeys and share how our iCAR platform at Singular Immune could contribute to the next wave of transformative treatments".
Tayo Sanders, Chief Business Officer, Singular Immune